Epigral Board Meeting May 2 for Q4 FY26 Results

Epigral Limited schedules board meeting on May 2, 2026 to approve audited financial results for Q4 and full year FY26.
Board will consider recommendation of final dividend for FY26 on equity shares of ₹10 each.
Meeting will be held at company's registered office and includes statutory auditors' report review.
Disclosure made pursuant to SEBI Listing Regulations Regulation 29 for shareholder information.